CK Life Sciences International Holdings (FRA:LSI) Median PS Value : €0.08 (As of May. 16, 2024)

View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. CK Life Sciences International Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.066. CK Life Sciences International Holdings's 10-Year median PS Ratio is 1.2121. Therefore, the Median PS Value for today is €0.08.

As of today (2024-05-16), CK Life Sciences International Holdings's share price is €0.0475. CK Life Sciences International Holdings's Median PS Value is €0.08. Therefore, CK Life Sciences International Holdings's Price to Median PS Value for today is 0.59.

The historical rank and industry rank for CK Life Sciences International Holdings's Median PS Value or its related term are showing as below:

FRA:LSI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.49 Med: 0.91 Max: 1.24
Current: 0.59

During the past 13 years, the highest Price to Median PS Value of CK Life Sciences International Holdings was 1.24. The lowest was 0.49. And the median was 0.91.

FRA:LSI's Price-to-Median-PS-Value is ranked better than
57.47% of 261 companies
in the Biotechnology industry
Industry Median: 0.7 vs FRA:LSI: 0.59

CK Life Sciences International Holdings Median PS Value Historical Data

The historical data trend for CK Life Sciences International Holdings's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Median PS Value Chart

CK Life Sciences International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Median PS Value

Get a 7-Day Free Trial

0.08

0.07

0.09

0.08

CK Life Sciences International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Median PS Value	Get a 7-Day Free Trial															0.09	-	0.09	-	0.08

Competitive Comparison of CK Life Sciences International Holdings's Median PS Value

For the Biotechnology subindustry, CK Life Sciences International Holdings's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CK Life Sciences International Holdings's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Price-to-Median-PS-Value falls into.

CK Life Sciences International Holdings Median PS Value Calculation

CK Life Sciences International Holdings's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	0.066	*	1.2121
	=	0.08

10-Year Median PS Ratio is 1.2121.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CK Life Sciences International Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.066.

CK Life Sciences International Holdings (FRA:LSI) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

CK Life Sciences International Holdings's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	0.0475	/	0.08
	=	0.59

CK Life Sciences International Holdings Median PS Value Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

CK Life Sciences International Holdings (FRA:LSI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (FRA:LSI) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

00775:Hong Kong

Address

2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG

Website

https://www.ck-lifesciences.com

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.